New & Noteworthy

February 2020

503B Compounding Agreement

Leiters Health

Leiters and Prodigy Health announce that they have entered into a national sales and marketing agreement. Through this strategic partnership, Prodigy Health will bring its ProdigyVision technology platform to the Leiters portfolio of 503B compounding sterile preparations in collaboration with the Leiters sales and marketing team. This agreement extends Leiters’ reach into the acute care market while expanding Prodigy Health’s service and product offering.

Leiters

Request More Information

Current Issue